USANA Health Sciences Inc (USNA)
USANA Health Sciences Inc. is a U.S.-listed common equity on the NYSE under the symbol USNA. The company develops, manufactures, and sells science-based nutritional, personal care, and skincare products across the Asia Pacific, the Americas, and Europe. Its operations are organized into two segments: Direct selling and Hiya Direct-To-Consumer.
USANA’s product lineup includes nutritional optimizers and supplements focused on cardiovascular, skeletal and structural, and digestive health, along with Essentials and CellSentials vitamin and mineral products for children and other age groups. The company also sells meal replacement shakes, snack bars, and related food products aimed at weight management, digestive health, energy, and hydration. Its skincare portfolio includes Celavive, a regimen designed for different skin types and ethnicities. In addition, USANA provides materials and online tools to support associates with product marketing and business development. The company was founded in 1992 and is headquartered in Salt Lake City, Utah.
Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.
| Ticker | Fair Value | Fair Value Upside/Downside | Fair Value Rating | Analyst Price Target | Analyst Target Upside/Downside | Analyst Target Rating | Overall Financial Health | Upcoming Dividend Ex-Date | Dividend Payment Date | Upcoming Dividend | Dividend Yield | Next Earnings Date | P/E Ratio | Price-to-Book Ratio | Price-to-Sales Ratio | Market Cap | Enterprise Value | Total Debt / Total Capital | Free Float / Shares Outstanding | Altman Z-Score | Payout Ratio | Free Cash Flow / Net Income |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
NYSE-USNA
|
$31.48
|
42.2% Upside
|
Undervalued
|
$39
|
76.2% Upside
|
Bargain
|
Fair
|
—
|
—
|
—
|
0.0%
|
August 4, 2026
|
45.8x
|
0.7x
|
0.4x
|
413.6 M
|
288.9 M
|
2.9%
|
53.4%
|
5.9
|
—
|
33.4%
|
